To discover whether the TM6SF2 rs58542926 variant also confers an increased risk of NAFLD-related HCC, we perform a secondary case–control analysis comparing the overall ‘combined’ cohort of NAFLD patients to a cohort of NAFLD–HCC patients. Here, TM6SF2 is linked to hepatocellular carcinoma.